• Topics

  • Formats

Organiser: MAPS

Traditionally, medical affairs teams have focused on scientific exchanges, primarily with the healthcare provider community. However, in recent years, medical affairs professionals have opened up to the exploration of opportunities to communicate to a wider nonscientific audience, including patients. It is no longer uncommon for medical affairs professionals to partner with their patient advocacy or engagement colleagues and become champions of patient involvement at different stages of the drug development process. With the value and unique insights that patients can bring from having the lived experience of their own condition recognized, the question now is, how can biopharmaceutical companies best partner with patients to ensure valued, ethical, and mutually beneficial interactions?

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?